Lycopene prevention of oxysterol-induced proinflammatory cytokine cascade in human macrophages: inhibition of NF-κB nuclear binding and increase in PPARγ expression

J Nutr Biochem. 2011 Mar;22(3):259-68. doi: 10.1016/j.jnutbio.2010.02.003. Epub 2010 Jun 22.

Abstract

It is now well accepted that oxysterols play important roles in the formation of atherosclerotic plaque, involving cytotoxic, pro-oxidant and proinflammatory processes. It has been recently suggested that tomato lycopene may act as a preventive agent in atherosclerosis, although the exact mechanism of such a protection is not clarified. The main aim of this study was to investigate whether lycopene is able to counteract oxysterol-induced proinflammatory cytokines cascade in human macrophages, limiting the formation of atherosclerotic plaque. Therefore, THP-1 macrophages were exposed to two different oxysterols, such as 7-keto-cholesterol (4-16 μM) and 25-hydroxycholesterol (2-4 μM), alone and in combination with lycopene (0.5-2 μM). Both oxysterols enhanced pro-inflammatory cytokine [interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factor α) secretion and mRNA levels in a dose-dependent manner, although at different extent. These effects were associated with an increased reactive oxygen species (ROS) production through an enhanced expression of NAD(P)H oxidase. Moreover, a net increment of phosphorylation of extracellular regulated kinase 1/2, p-38 and Jun N-terminal kinase and of nuclear factor kB (NF-κB) nuclear binding was observed. Lycopene prevented oxysterol-induced increase in pro-inflammatory cytokine secretion and expression. Such an effect was accompanied by an inhibition of oxysterol-induced ROS production, mitogen-activated protein kinase phosphorylation and NF-κB activation. The inhibition of oxysterol-induced cytokine stimulation was also mimicked by the specific NF-κB inhibitor pyrrolidine dithiocarbamate. Moreover, the carotenoid increased peroxisome proliferator-activated receptor γ levels in THP-1 macrophages. Taken all together, these data bring new information on the anti-atherogenic properties of lycopene, and on its mechanisms of action in atherosclerosis prevention.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carotenoids / pharmacology*
  • Cell Line
  • Cytokines / biosynthesis*
  • Humans
  • Hydroxycholesterols / adverse effects*
  • Interleukin-1beta / metabolism
  • Interleukin-6 / metabolism
  • Interleukin-8 / metabolism
  • Ketocholesterols / adverse effects*
  • Lycopene
  • Macrophages / metabolism*
  • Mitogen-Activated Protein Kinases / metabolism
  • NADPH Oxidases / metabolism
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • PPAR gamma / genetics
  • PPAR gamma / metabolism*
  • Phosphorylation
  • Plaque, Atherosclerotic / metabolism
  • Protein Binding
  • RNA, Messenger / analysis
  • Reactive Oxygen Species / analysis
  • Signal Transduction
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • CXCL8 protein, human
  • Cytokines
  • Hydroxycholesterols
  • IL6 protein, human
  • Interleukin-1beta
  • Interleukin-6
  • Interleukin-8
  • Ketocholesterols
  • NF-kappa B
  • PPAR gamma
  • RNA, Messenger
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • Carotenoids
  • 25-hydroxycholesterol
  • NADPH Oxidases
  • Mitogen-Activated Protein Kinases
  • 7-ketocholesterol
  • Lycopene